Comparative in vitro activity of a new quinolone, fleroxacin, against respiratory pathogens from patients with cystic fibrosis.

We evaluated fleroxacin, a newer fluoroquinolone, against isolates from sputum from patients with cystic fibrosis. These isolates included rough and mucoid Pseudomonas aeruginosa, Pseudomonas cepacia, Staphylococcus aureus, Haemophilus influenzae, and Escherichia coli. Selected isolates were tested...

Descrición completa

Detalles Bibliográficos

Publicado en:	Antimicrob Agents Chemother
Principais autores:	Akaniro, J C, Vidaurre, C E, Stutman, H R, Marks, M I
Formato:	Artigo
Idioma:	Inglês
Publicado:	American Society for Microbiology (ASM) 1990
Assuntos:	Research Article
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC171958/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2127170/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.34.10.1880
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!